The study, publicized in the peer-reviewed journal PLOS Medicine, involved the combing of data from the Canadian province of Ontario between 2007 up until 2015.
For the study, researchers examined patterns of protein expressed in over 2,000 human brain and close to 400 cerebrospinal fluid samples belonging to individuals with and without the presence of neurodegeneration.